Clinical Trial: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Multicenter, Phase 1/1b Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Brief Summary:
This study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of JANX008 in adult subjects with advanced or metastatic carcinoma expressing EGFR.
Read more